A new study has found ineffective co-ordination of services and fragmented care plans in England has resulted in very little improving for dementia caregivers in…
Results from the National Institutes of Health’s Drug Repurposing for Effective Alzheimer’s Medicines (DREAM) study show that sildenafil (Viagra) and tadalafil (Cialis) may not be…
Evidence in mouse and human brain tissue reveals a mechanism that may explain the sex-based differences in Alzheimer’s disease, including why females are more vulnerable.…
Larry Griner resigned from his job in California and moved back to his childhood home in Baltimore nearly five years ago so he could care…
Using demographic information, brain imaging test results and genetic biomarkers, researchers at Washington University School of Medicine in St. Louis have developed an algorithm that…
New research—which studied genomic changes in different types of brain cells—has yielded a potentially surprising result: many of the changes in Alzheimer’s disease are in…
The development of anti-amyloid monoclonal antibodies that may slow the progression of Alzheimer’s disease by breaking down amyloid plaques, a hallmark of the disease, has…
A study of nearly 600,000 people in England shows that suicide risk in the first three months following a dementia diagnosis for patients aged under…
Neurons in an area of the brain responsible for memory (known as the entorhinal cortex) were significantly larger in super agers (80 years and older)…
A large, nationwide study from Taiwan shows that people with a specific type of glaucoma, called normal-tension glaucoma, are at high risk for developing Alzheimer’s…